Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Ellagic Acid Derivatives: Possible Drugs Against Metapneumovirus?

Version 1 : Received: 5 October 2022 / Approved: 6 October 2022 / Online: 6 October 2022 (08:40:19 CEST)

How to cite: Artamonova, E. A.; Abdullatypov, A. V. Ellagic Acid Derivatives: Possible Drugs Against Metapneumovirus?. Preprints 2022, 2022100055. https://doi.org/10.20944/preprints202210.0055.v1 Artamonova, E. A.; Abdullatypov, A. V. Ellagic Acid Derivatives: Possible Drugs Against Metapneumovirus?. Preprints 2022, 2022100055. https://doi.org/10.20944/preprints202210.0055.v1

Abstract

Human metapneumovirus is one of major causes of common cold among children, especially infants. Its key enzyme is RNA-dependent RNA-polymerase, which performs both replication and transcription, including capping and cap methylation. The goal of the work is to find possible inhibitors of RNA-dependent RNA-polymerase across the active compounds of Rosaceae plants. The candidates were selected by molecular docking to cap-transferring domain of RNA-polymerase (PDB ID: 4UCZ) in Autodock VINA. Among all the substances tested by docking, ellagic acid derivatives showed the most promising results (affinity values below -10 kcal/mol). Hence, they could be treated as possible candidate drugs against metapneumoviral infection after experimental examination. The main advantage of using these substances should be their low toxicity, which is quite uncommon for selective RNA polymerase inhibitors used in clinical practice. Occurrence of ellagic acid derivatives among the plants from Rosaceae family like raspberry could explain their effect during common cold.

Keywords

metapneumovirus; molecular docking; phenolic compounds; glycosides; ellagic acid; RNA-dependent RNA-polymerase

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.